DK3313436T3 - Multivalent pneumokok-konjugatvaccine - Google Patents
Multivalent pneumokok-konjugatvaccine Download PDFInfo
- Publication number
- DK3313436T3 DK3313436T3 DK16753710.9T DK16753710T DK3313436T3 DK 3313436 T3 DK3313436 T3 DK 3313436T3 DK 16753710 T DK16753710 T DK 16753710T DK 3313436 T3 DK3313436 T3 DK 3313436T3
- Authority
- DK
- Denmark
- Prior art keywords
- pneumokok
- multivalent
- conjugate vaccine
- vaccine
- conjugate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6415—Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3140CH2015 | 2015-06-23 | ||
| PCT/IN2016/000157 WO2016207905A2 (en) | 2015-06-23 | 2016-06-21 | Multivalent pneumococcal conjugate vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3313436T3 true DK3313436T3 (da) | 2021-03-08 |
Family
ID=56738144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16753710.9T DK3313436T3 (da) | 2015-06-23 | 2016-06-21 | Multivalent pneumokok-konjugatvaccine |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11147863B2 (da) |
| EP (1) | EP3313436B1 (da) |
| JP (1) | JP6808658B2 (da) |
| CN (1) | CN107810010A (da) |
| AU (1) | AU2016285017B2 (da) |
| BR (1) | BR112017028130A2 (da) |
| CA (1) | CA2989230A1 (da) |
| CY (1) | CY1123838T1 (da) |
| DK (1) | DK3313436T3 (da) |
| EA (1) | EA037373B1 (da) |
| ES (1) | ES2857474T3 (da) |
| HR (1) | HRP20210373T1 (da) |
| HU (1) | HUE053272T2 (da) |
| LT (1) | LT3313436T (da) |
| MX (1) | MX2017016828A (da) |
| PL (1) | PL3313436T3 (da) |
| PT (1) | PT3313436T (da) |
| RS (1) | RS61440B1 (da) |
| SA (1) | SA517390539B1 (da) |
| SI (1) | SI3313436T1 (da) |
| WO (1) | WO2016207905A2 (da) |
| ZA (1) | ZA201708713B (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| MY192183A (en) * | 2015-07-21 | 2022-08-05 | Pfizer | Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof |
| JP7164200B2 (ja) | 2016-03-31 | 2022-11-01 | ポゴナ， エルエルシー | サッカライド－ポリペプチドコンジュゲートの組成物およびその使用の方法 |
| EP3518965A1 (en) | 2016-09-30 | 2019-08-07 | Biological E Limited | Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| WO2018126229A2 (en) | 2016-12-30 | 2018-07-05 | Sutrovax, Inc. | Polypeptide-antigen conjugates with non-natural amino acids |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| BR112019026192B1 (pt) * | 2017-06-10 | 2022-05-10 | Inventprise, Llc | Vacinas de conjugado multivalente com polissacarídeos de conjugado bivalente ou multivalente que fornecem imunogenicidade e avidez melhoradas |
| CN108003240B (zh) * | 2017-12-04 | 2020-06-05 | 西安德轩驰生物科技有限公司 | 一种海水养殖鱼多联抗独特型卵黄抗体疫苗及其制备方法 |
| GEP20227420B (en) | 2017-12-06 | 2022-10-10 | Merck Sharp & Dohme Llc | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| AU2019215216A1 (en) | 2018-02-05 | 2020-07-23 | Sk Bioscience Co., Ltd. | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| BR112020021296A2 (pt) | 2018-04-18 | 2021-01-26 | Sk Bioscience Co., Ltd. | polissacarídeo capsular de streptococcus pneumoniae e conjugado imunogênico do mesmo |
| JP2022525492A (ja) * | 2018-10-12 | 2022-05-17 | バイオロジカル イー リミテッド | 多価肺炎球菌多糖類－タンパク質コンジュゲートワクチン |
| JOP20210148A1 (ar) | 2018-12-19 | 2023-01-30 | Merck Sharp & Dohme | تركيبات تشتمل على متقارنات بولي سكاريد-بروتين للمكورات العقدية الرئوية وطرق استخدامها |
| EP3900739A1 (en) | 2020-04-21 | 2021-10-27 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5360897A (en) | 1981-08-31 | 1994-11-01 | The University Of Rochester | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad |
| CA2129899C (en) | 1992-02-11 | 2011-01-04 | James J. Mond | Dual carrier immunogenic construct |
| ES2231770T3 (es) | 1993-03-05 | 2005-05-16 | Wyeth Holdings Corporation | Nuevos plasmidos para la produccion de proteina crm y toxina difterica. |
| JP3828145B2 (ja) | 1993-09-22 | 2006-10-04 | ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 免疫原性構成物の製造のための新規シアン化試薬を使った可溶性炭水化物の活性化方法 |
| ATE241384T1 (de) | 1995-03-22 | 2003-06-15 | Jackson H M Found Military Med | Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden |
| FR2763244B1 (fr) | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| US8048432B2 (en) | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CN102716480B (zh) | 2005-04-08 | 2023-03-21 | 惠氏有限责任公司 | 多价肺炎球菌多糖-蛋白质缀合物组合物 |
| US7955605B2 (en) | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CA2808919C (en) | 2005-12-22 | 2016-04-19 | Glaxosmithkline Biologicals S.A. | Streptococcus pneumoniae capsular saccharide vaccine |
| KR101411425B1 (ko) | 2006-03-17 | 2014-06-24 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
| EP2687228B1 (en) | 2007-06-26 | 2017-07-19 | GlaxoSmithKline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| CN101590224A (zh) * | 2009-06-30 | 2009-12-02 | 广州精达医学科技有限公司 | 高效14价肺炎球菌结合疫苗 |
| TW201136603A (en) | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| GB201003924D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| KR102057217B1 (ko) | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| CN103623401A (zh) | 2012-08-23 | 2014-03-12 | 北京科兴中维生物技术有限公司 | 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法 |
| CN103656631B (zh) | 2012-09-24 | 2015-08-19 | 北京科兴中维生物技术有限公司 | 多价肺炎球菌荚膜多糖-蛋白缀合物组合物及其制备方法 |
| CN103656632B (zh) | 2012-09-24 | 2016-01-13 | 北京科兴中维生物技术有限公司 | 多价肺炎球菌荚膜多糖组合物、其制备方法及应用 |
| KR20140075196A (ko) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| KR20140075201A (ko) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| CN104069488A (zh) | 2013-03-29 | 2014-10-01 | 北京科兴中维生物技术有限公司 | 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法 |
| EA035117B1 (ru) | 2014-11-20 | 2020-04-29 | Байолоджикал И Лимитед | Кодон-оптимизированный полинуклеотид для экспрессии crmна высоком уровне |
-
2016
- 2016-06-21 DK DK16753710.9T patent/DK3313436T3/da active
- 2016-06-21 CA CA2989230A patent/CA2989230A1/en active Pending
- 2016-06-21 SI SI201631120T patent/SI3313436T1/sl unknown
- 2016-06-21 RS RS20210164A patent/RS61440B1/sr unknown
- 2016-06-21 US US15/772,771 patent/US11147863B2/en active Active
- 2016-06-21 MX MX2017016828A patent/MX2017016828A/es unknown
- 2016-06-21 PT PT167537109T patent/PT3313436T/pt unknown
- 2016-06-21 ES ES16753710T patent/ES2857474T3/es active Active
- 2016-06-21 CN CN201680037079.2A patent/CN107810010A/zh active Pending
- 2016-06-21 BR BR112017028130A patent/BR112017028130A2/pt active Search and Examination
- 2016-06-21 WO PCT/IN2016/000157 patent/WO2016207905A2/en active Application Filing
- 2016-06-21 EP EP16753710.9A patent/EP3313436B1/en active Active
- 2016-06-21 PL PL16753710T patent/PL3313436T3/pl unknown
- 2016-06-21 EA EA201890431A patent/EA037373B1/ru unknown
- 2016-06-21 JP JP2017566871A patent/JP6808658B2/ja active Active
- 2016-06-21 LT LTEP16753710.9T patent/LT3313436T/lt unknown
- 2016-06-21 HU HUE16753710A patent/HUE053272T2/hu unknown
- 2016-06-21 AU AU2016285017A patent/AU2016285017B2/en active Active
-
2017
- 2017-12-13 SA SA517390539A patent/SA517390539B1/ar unknown
- 2017-12-20 ZA ZA2017/08713A patent/ZA201708713B/en unknown
-
2021
- 2021-02-18 CY CY20211100136T patent/CY1123838T1/el unknown
- 2021-03-03 HR HRP20210373TT patent/HRP20210373T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3313436T (pt) | 2021-02-25 |
| EA201890431A1 (ru) | 2018-06-29 |
| US11147863B2 (en) | 2021-10-19 |
| RS61440B1 (sr) | 2021-03-31 |
| EA037373B1 (ru) | 2021-03-22 |
| HRP20210373T1 (hr) | 2021-04-30 |
| US20190240308A1 (en) | 2019-08-08 |
| LT3313436T (lt) | 2021-06-10 |
| SI3313436T1 (sl) | 2021-09-30 |
| HUE053272T2 (hu) | 2021-06-28 |
| WO2016207905A2 (en) | 2016-12-29 |
| BR112017028130A2 (pt) | 2018-08-28 |
| MX2017016828A (es) | 2018-09-18 |
| JP2018518512A (ja) | 2018-07-12 |
| EP3313436B1 (en) | 2020-12-23 |
| CY1123838T1 (el) | 2022-05-27 |
| WO2016207905A3 (en) | 2017-02-09 |
| EP3313436A2 (en) | 2018-05-02 |
| JP6808658B2 (ja) | 2021-01-06 |
| CA2989230A1 (en) | 2016-12-29 |
| CN107810010A (zh) | 2018-03-16 |
| ES2857474T3 (es) | 2021-09-29 |
| AU2016285017A1 (en) | 2018-01-04 |
| PL3313436T3 (pl) | 2021-06-14 |
| SA517390539B1 (ar) | 2021-05-24 |
| AU2016285017B2 (en) | 2022-03-03 |
| ZA201708713B (en) | 2019-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR21C1030I2 (fr) | Conjugué anticorps anti-her2-médicament | |
| DK3393510T3 (da) | Zikavirusvaccine | |
| DK3313436T3 (da) | Multivalent pneumokok-konjugatvaccine | |
| MA46766A (fr) | Vaccin antigrippal | |
| IL253187A0 (en) | New vaccines based on multivalent nanoparticles | |
| DK3592393T3 (da) | Frigørbare konjugater | |
| MA46255A (fr) | Vaccins anticancéreux | |
| DK3129063T3 (da) | Anti-her3-antistof-lægemiddelkonjugat | |
| DK3268047T3 (da) | Amatoxin/antistof-konjugater | |
| DK3119885T3 (da) | Antistof-fynomer-konjugater | |
| DK3218504T3 (da) | Trisegmenterede arenavira som vaccinevektorer | |
| DK3148591T3 (da) | Nanopartikel-lægemiddelkonjugater | |
| DK3198111T3 (da) | Forbedret prop | |
| CL2016002146A1 (es) | Plásmidos inmunoestimuladores | |
| DK3129007T3 (da) | Vaccinesammensætninger | |
| DK3199161T3 (da) | Farmaceutisk præparat | |
| ZA201800928B (en) | Multivalent vlp conjugates | |
| DK3166473T3 (da) | Oftalmoskoper | |
| IL264605A (en) | A multivalent vaccine | |
| DK3355933T3 (da) | Adeninkonjugatforbindelser og deres anvendelse som vaccineadjuvanser | |
| DK3302016T3 (da) | Ophængt plov | |
| DK3228706T3 (da) | Coekspressionsplasmid | |
| DK3171961T3 (da) | Monolitisk honeycombstruktur | |
| GB201506041D0 (en) | Avian vaccine | |
| DK3405212T3 (da) | Cancervacciner |